spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 5


Fig. 5. JP-45 interacts with the AID domain on the I-II loop of Cav1.1. (A) GST-I-II loop fusion protein or the GST-AID containing domain encompassed within Cav1.1 residues 336-384 were incubated with His-tagged JP-45 domain-2 fusion protein. Pull-down was performed as described in Fig. 3; proteins in the void (V), last wash (LW) or bound to the glutathione resin (B) were separated on a 12.5% SDS-PAGE, transferred onto nitrocellulose and probed with affinity-purified anti-JP-45 Ab. (B) Synthetic biotinylated peptides corresponding to the AID sequence or an unrelated biotinylated peptide were used to coat neutroavidine beads, which were subsequently incubated with His-JP-45 domain 2. Proteins present in the void, last wash or bound to the beads were separated on a 12.5% SDS-PAGE, transferred onto nitrocellulose and the immunopositive band was visualized using anti-His-tag commercial Abs. (C) A His-tagged fusion protein encompassing domain 2 JP-45 was prepared as described in Materials and Methods. Although the fusion protein migrated slower in SDS-PAGE, its identity was verified by direct sequencing (not shown) and by immunoblotting with anti-His Ab. Note that treatment of the fusion protein with DTT+DEPC eliminated its immunoreactivity.





Right arrow Return to article